1887

Abstract

The roles of topoisomerases I and II in Epstein—Barr virus (EBV) replication were investigated using Raji cells infected with EBV. The topoisomerase II inhibitor ellipticine inhibited the synthesis of EBV polypeptides at concentrations which did not affect total protein synthesis. Slot blot analysis of total cellular DNA showed that camptothecin and ellipticine inhibited replication of progeny EBV DNA in superinfected Raji cells at concentrations which did not inhibit synthesis of EBV early polypeptides prerequisite for EBV DNA replication. Analysis of the structure of EBV DNA termini demonstrated that both inhibitors affected the replicating EBV DNA. Gardella gel electrophoresis showed that both inhibitors affected the formation of the linear form of EBV DNA. However, restriction analysis of EBV DNA in superinfected Raji cells demonstrated that both inhibitors degraded neither endogenous nor exogenous EBV DNA. Cell viability was not affected by either inhibitor at the concentrations tested. These findings suggest that topoisomerase II is required for expression of the EBV genome and that both topoisomerases I and II are involved in replication of the EBV genome during the lytic phase of the life cycle. The effects of topoisomerase inhibitors on the circular form of EBV DNA during virus replication are discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-10-2263
1993-10-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/10/JV0740102263.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-10-2263&mimeType=html&fmt=ahah

References

  1. Benson J. D., Huang E. S. 1988; Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome. Journal of Virology 62:4797–4800
    [Google Scholar]
  2. Champoux J. I. 1988; Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin. Journal of Virology 28:3675–3683
    [Google Scholar]
  3. Drlica K., Franco R. J. 1988; Inhibitors of DNA topoisomerases. Biochemistry 27:2253–2259
    [Google Scholar]
  4. Ebert S. N., Shtrom S. S., Muller M. T. 1990; Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent. Journal of Virology 64:4059–4066
    [Google Scholar]
  5. Foglesong P. D., Bauer W. R. 1984; Effect of ATP and inhibitory factors on the activity of vaccinia virus type I topoisomerase. Journal of Virology 49:1–8
    [Google Scholar]
  6. Gardella T., Medveczky P., Sairennji T., Mulder C. 1984; Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. Journal of Virology 50:248–254
    [Google Scholar]
  7. Gu M.-L., Rhode S. L. 1991; Autonomous parvovirus DNA replication requires topoisomerase I and its activity is increased during infection. Journal of Virology 65:1662–1665
    [Google Scholar]
  8. Hsiang Y.-H., Hertzberg R., Hecht S., Liu L. F. 1985; Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. Journal of Biological Chemistry 260:14873–14878
    [Google Scholar]
  9. Katz B., Raab-Traub N., Miller G. 1989; Latent and replicating forms of Epstein-Barr virus DNA in lymphoma and lyrnpho-proliferative diseases. Journal of Infectious Diseases 160:589–598
    [Google Scholar]
  10. Kawanishi M., Sugawara K., Ito Y. 1981; Epstein-Barr virus-induced polypeptides: a comparative study with superinfected Raji, IUdR-treated, and n-butyrate-treated P3HR-1 cells. Virology 109:72–81
    [Google Scholar]
  11. Maxwell A., Gellert M. 1985; Mechanistic aspects of DNA topoisomerases. Advances in Protein Chemistry 38:69–107
    [Google Scholar]
  12. Nishiyama Y., Fujioka H., Tsurumi T., Yamamoto N., Maeno K., Yoshida S., Shimokata K. 1987; Effects of the epipodophyllotoxin VP-16-213 on herpes simplex virus type 2 replication. Journal of General Virology 68:913–918
    [Google Scholar]
  13. Priel E., Showalter S. D., Roberts M., Oroszlan S., Segal S., Aboud M., Blair D. G. 1990; Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. EMBO Journal 9:4167–4172
    [Google Scholar]
  14. Priel E., Showalter S. D., Roberts M., Oroszlan S., Blair D. G. 1991; The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells. Journal of Virology 65:4137–4141
    [Google Scholar]
  15. Raab-Traub N., Flynn K. 1986; The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 22:883–889
    [Google Scholar]
  16. Richter A., Strausfeld U. 1988; Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro. Nucleic Acids Research 16:10119–10129
    [Google Scholar]
  17. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual 2nd edn New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  18. Schaack J., Schedl P., Shenk T. 1990a; Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication. Journal of Virology 64:78–85
    [Google Scholar]
  19. Schaak J., Schedl P., Shenk T. 1990b; Transcription of adenovirus and HeLa genes in the presence of drugs that inhibit topoisomerase I and II function. Nucleic Acids Research 18:1499–1508
    [Google Scholar]
  20. Snapka R. M. 1986; Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication. Molecular and Cellular Biology 6:4221–41227
    [Google Scholar]
  21. Tewey, K. M., Chen G.-L., Nelson E. M., Liu L. F. 1984; Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. Journal of Biological Chemistry 259:9182–9187
    [Google Scholar]
  22. Wang H.-P., Rogler C. E. 1991; Topoisomerase I-mediated integration of hepadnavirus DNA in vitro. Journal of Virology 65:2381–2392
    [Google Scholar]
  23. Wang J. C. 1985; DNA topoisomerases. Annual Review of Biochemistry 54:665–697
    [Google Scholar]
  24. Wong M.-L., Hsu M.-T. 1990; Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome. Journal of Virology 64:691–699
    [Google Scholar]
  25. Yamada Y., Yamamoto N., Maeno K., Nishiyama Y. 1990; Role of DNA topoisomerase I in the replication of herpes simplex virus type 2. Archives of Virology 110121–127
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-10-2263
Loading
/content/journal/jgv/10.1099/0022-1317-74-10-2263
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error